The breakthrough and dilemma of CDK4/6 inhibitors in combination with endocrine therapy
YE Songqing
Keywords：Breast tumorCDK4/6 inhibitorEstrogen receptorProgesterone receptorHuman epidermal growth factor receptor-2
Publication Date：2023-08-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 404-409 )